Paul Hamberg
Association of British Orchestras(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, Cancer Genomics and Diagnostics, Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis(2018)408 cited
- → Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells(2015)239 cited
- → The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact(2019)207 cited
- → (Pre-)Clinical Pharmacology and Activity of Pazopanib, a Novel Multikinase Angiogenesis Inhibitor(2010)151 cited
- → Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration‐resistant prostate cancer who progress after docetaxel and abiraterone treatment(2013)135 cited
- → Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors(2010)108 cited
- → Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells(2021)91 cited
- → A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy(2018)89 cited
- → Local NSAID Gel (Eltenac) in the Treatment of Osteoarthritis of the Knee: A double blind study comparing eltenac with oral diclofenac and placebo gel(1997)75 cited
- → Dose-escalation models for combination phase I trials in oncology(2010)70 cited